Drugs / RO5303253
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01181024 | Apr → Oct 2010 | chronic hepatitis C virus infection | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO5303253 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01181024 ↗ |